Impact of 3-year lifestyle intervention on postprandial glucose metabolism: the SLIM study (Q46620358)

23 December 2017

title

Impact of 3-year lifestyle intervention on postprandial glucose metabolism: the SLIM study (English)

1 reference

23 December 2017

author

Edith J.M. Feskens

3

1 reference

23 December 2017

author name string

C Roumen

1

1 reference

23 December 2017

E Corpeleijn

2

1 reference

23 December 2017

M Mensink

4

1 reference

23 December 2017

W H M Saris

5

1 reference

23 December 2017

E E Blaak

6

1 reference

23 December 2017

publication date

1 May 2008

1 reference

23 December 2017

published in

Diabetic Medicine

1 reference

23 December 2017

volume

25

1 reference

23 December 2017

page(s)

597-605

1 reference

23 December 2017

issue

5

1 reference

23 December 2017

Lifestyle intervention according to general recommendations improves glucose tolerance

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02417.X

The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02417.X

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02417.X

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02417.X

Plasma free Fatty Acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02417.X

Improvements in glucose tolerance and insulin sensitivity after lifestyle intervention are related to changes in serum fatty acid profile and desaturase activities: the SLIM study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02417.X

Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02417.X

Postprandial dysmetabolism and cardiovascular disease in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02417.X

Development of the multiple metabolic syndrome: an epidemiologic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02417.X

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02417.X

Impaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02417.X

Study on lifestyle-intervention and impaired glucose tolerance Maastricht (SLIM): design and screening results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02417.X

Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02417.X

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02417.X

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02417.X

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02417.X

Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02417.X

The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02417.X

Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02417.X

Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02417.X

Adipose tissue fatty acid metabolism and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02417.X

Lifestyle intervention and fatty acid metabolism in glucose-intolerant subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02417.X

Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02417.X

Subclinical states of glucose intolerance and risk of death in the U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02417.X

Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02417.X

Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02417.X

Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02417.X

Improved fibrinolysis by an intensive lifestyle intervention in subjects with impaired glucose tolerance. The Finnish Diabetes Prevention Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02417.X

10.1111/J.1464-5491.2008.02417.X

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

PubMed ID

18445174

1 reference

23 December 2017